Hon. David Kappos

David J. Kappos is a partner at Cravath.  He is a leader in the field of intellectual property, including IP management and strategy, the development of global IP norms, laws and practices as well as commercialization and enforcement of innovation-based assets.  From 2009 to 2013, Mr. Kappos served as Under Secretary of Commerce and Director of the U.S. Patent and Trademark Office (USPTO).  In that role, he advised the President, the Secretary of Commerce and the Administration on IP policy matters.  Mr. Kappos led the Agency in dramatically reengineering its entire management and operational systems and its engagement with the global innovation community.  He was instrumental in achieving the greatest legislative reform of the U.S. patent system in generations through passage and implementation of the Leahy‑Smith America Invents Act, signed into law by President Obama in September 2011.

Prior to leading the USPTO, Mr. Kappos held several executive posts in the legal department of IBM, the world’s largest patent holder.  From 2003 to 2009, he served as the company’s chief intellectual property lawyer.  In that capacity, he managed global intellectual property activities for IBM, including all aspects of patent, trademark, copyright and trade secret protection and exploitation.  During his more than 25 years at IBM, he also served in a variety of other roles including litigation counsel and Asia Pacific IP counsel, where he led all aspects of IP protection, including licensing, transactions support and M&A activity for the Asia/Pacific region.

Safeguarding Human Invention in the Age of Artificial Intelligence

By Alexander Kersten Introduction On October 30, President Joe Biden issued the Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence. This comes at a time when artificial intelligence (AI)’s anticipated capabilities and applications are expected to have a tremendous impact on the future
Read More

Letter to Congress Correcting False Claims About Bayh-Dale Act and § 1498 on Drug Price Controls

On September 28th, 2023, a letter was sent to the Senate Health, Education, Labor and Pensions Committee, the Chair and Ranking Member of the House Ways and Means Committee, and to Secretary Becerra correcting false claims that the federal government can use the Bayh-Dole Act or § 1498 to impose
Read More

Dr. Kirti Gupta – Testimony: Innovating Ideas Around Standards and Intellectual Property

On September 20th, 2023, LeadershIP Executive Director Dr. Kirti Gupta testified for the ITA-NIST-USPTO Listening Session on Innovating Ideas Around Standards and Intellectual Property.    Transcript: Good afternoon. My name is Dr. Kirti Gupta and I am speaking on behalf of the Center for Strategic and International Studies (CSIS). Let
Read More